SG Americas Securities
CNTX icon

SG Americas Securities’s Context Therapeutics CNTX Stock Holding History

SG Americas Securities’s Portfolio CNTX Stock Details CNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9K Buy
+15,462
New +$31.3K ﹤0.01% 3301

Other funds holding CNTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SG Americas Securities's CNTX Position: Q2 2026 in Review

SG Americas Securities opened a new position in Context Therapeutics (CNTX) in Q2 2026: 15,462 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #3301 among its holdings.

17 funds tracked by Wall St. Rank hold CNTX as of Q2 2026.

  • SG Americas Securities held 15,462 shares of Context Therapeutics worth $9K as of Q2 2026.
  • Context Therapeutics was a new SG Americas Securities position in Q2 2026.
  • Context Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3301 holding.
  • 17 funds tracked by Wall St. Rank held Context Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.